ADVB — ADVANCED BIOMED Balance Sheet
0.000.00%
- $39.17m
- $36.51m
Annual balance sheet for ADVANCED BIOMED, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 0.066 | 4.78 | 2.62 | 2.61 |
Net Total Receivables | 0 | 0.139 | 0.147 | 0.161 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 0.913 | 5.01 | 2.79 | 3.05 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0.093 | 1.23 | 0.954 | 0.651 |
Net Intangible Assets | ||||
Other Long Term Assets | ||||
Total Assets | 1.01 | 6.71 | 4.6 | 4.46 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.028 | 2.99 | 3.28 | 2.73 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 0.03 | 3.22 | 3.29 | 2.8 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 0.976 | 3.49 | 1.31 | 1.66 |
Total Liabilities & Shareholders' Equity | 1.01 | 6.71 | 4.6 | 4.46 |
Total Common Shares Outstanding |